What is Nota Laboratories?
Nota Laboratories is a forward-thinking company dedicated to developing innovative healthcare solutions. Its core technology leverages the therapeutic capabilities of Nitric Oxide, a versatile molecule with demonstrated antimicrobial, antiviral, anti-inflammatory, and anti-thrombotic properties. The company aims to apply this agent across a targeted spectrum of medical applications, addressing unmet needs in patient care and disease management. The recent capital infusion is expected to accelerate the development and commercialization of these groundbreaking therapies.
How much funding has Nota Laboratories raised?
Nota Laboratories has raised a total of $74K across 1 funding round:
Debt
$74K
Debt (2021): $74K with participation from PPP
What's next for Nota Laboratories?
With significant backing at the Series B/C stage, Nota Laboratories is poised for accelerated growth and market penetration. The company's focus on Nitric Oxide-based therapies positions it at the intersection of advanced materials science and clinical medicine. Future strategic initiatives will likely involve expanding its product pipeline, scaling manufacturing capabilities, and forging key partnerships within the healthcare ecosystem. Continued investment in research and development will be crucial to fully realize the therapeutic potential of Nitric Oxide across its targeted medical applications.
See full Nota Laboratories company page
